BioNexus Gene Lab Corp. (BGLC)
$1.29+3.20%Close
SELLCRISIS · day 11
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3M
- Beta
- 2.21
- P/E (TTM)
- -0.98
- Short % float
- 0.78%
- Days to cover
- 1.5
- SI change
- -22.4%
- 1W
- +1.57%
- 1M
- -12.84%
- vs SPY 1W
- +0.41%
- vs SPY 1M
- -15.83%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on BGLC?
- LOPJLB’s latest quantitative signal on BioNexus Gene Lab Corp. (BGLC) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is BGLC in?
- BioNexus Gene Lab Corp. (BGLC) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does BioNexus Gene Lab Corp. (BGLC) do?
- BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the m…